Cobratide for Injection – 70?g Lyophilized Powder | Neurotrophic Peptide for Pain & Neural Therapy

Description Contents hide 1 Cobratide for Injection Product Specifications 2 Cobratide for Injection Mechanism of Action 3 Research Applications & Pharmacology 4 Safety Profile & Handling 4.1 ?? Research?Use Disclaimer Cobratide for Injection Product SpecificationsAttributeDetailsProduct NameCobratide for Injection Wholesale priceGeneric NameCobrotoxin peptideCAS Number100123-78-2 (approx., specific to purified peptide variant)Molecular FormulaC???H???N??O?? (typical for cobrotoxin family peptides)Molecular Weight~3020?g/mol (varies slightly with glycosylation)Dosage FormLyophilized powder for reconstitutionStrength70??g per vialPack Size5 vials per boxApproval NumberH20003660 (China NMPA)Product Code86903091000198ManufacturerHenan Xintai Pharmaceutical Co., Ltd.Barcode6974351310016Storage2–8?°C; protect from light and moistureIntended UseLaboratory research onlyCobratide for Injection Mechanism of ActionCobratide blocks voltage-gated sodium channels in peripheral sensory neurons, interrupting pain signal transmission. It also promotes nerve regeneration and reduces inflammation through modulation of neurotrophic factors.Additionally, it may inhibit muscle contraction via interaction with nicotinic acetylcholine receptors at the neuromuscular junction.Research Applications & PharmacologyNeurogenic pain models: Peripheral nerve injury, postherpetic neuralgia, diabetic neuropathyNeuroregeneration studies: Enhances nerve repair and myelin sheath recoveryIon channel studies: Sodium-channel antagonist effects in sensory neuronsInflammatory research: Modulates cytokine and prostaglandin expressionIn vitro assays: Used in peptide neurobiology, venom pharmacodynamics, and molecular pain researchPharmacokinetics:Rapid onset, moderate tissue bindingProtein peptide clearance primarily via renal excretionShort half-life in rodents, prolonged in higher mammalsSafety Profile & HandlingPotential effects: Localized muscle flaccidity, mild hypotension, rare hypersensitivity (in animal models).Protective measures: Use PPE, sterile reconstitution, avoid inhalation or injection.Handling guidance: Reconstitute under aseptic conditions. Dispose of biological waste per lab protocols.Storage: 2–8?°C; avoid freeze-thaw cycles.?? Research?Use DisclaimerThis product is intended solely for laboratory research purposes. It is not approved for human or veterinary use. Improper use may pose health risks and invalidate experimental results.